Results
6
6 companies
Delcath Systems
Market Cap: US$388.3m
An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
DCTH
US$11.65
7D
5.7%
1Y
20.5%
DexCom
Market Cap: US$31.7b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$80.51
7D
6.9%
1Y
17.3%
electroCore
Market Cap: US$37.3m
A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
ECOR
US$4.89
7D
-7.9%
1Y
-17.7%
Alignment Healthcare
Market Cap: US$3.2b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$15.86
7D
-3.1%
1Y
66.9%
Lifeward
Market Cap: US$8.7m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$0.53
7D
-16.5%
1Y
-82.8%
TransMedics Group
Market Cap: US$3.5b
A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
TMDX
US$104.01
7D
-9.5%
1Y
-25.6%